Cortisol Homeostasis in the Epidermis is Influenced by Topical Corticosteroids in Patients with Atopic Dermatitis

被引:5
|
作者
Fukaya, Mototsugu [1 ]
机构
[1] Tsurumai Kouen Clin, Naka Ku, 5-20-6 Chiyoda, Nagoya, Aichi 4600012, Japan
关键词
Cortisol; rebound; red skin syndrome; topical steroid addiction; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; STEROID ADDICTION; HUMAN-SKIN; EXPRESSION; ATROPHY;
D O I
10.4103/ijd.IJD_702_16
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: The skin produces cortisol by itself and regulates its own proliferation and differentiation. There is a possibility that topical corticosteroids (TCSs) influence the cortisol homeostasis in the skin. Aims and Objectives: The author described the density and distribution of cortisol and its parties in the epidermis after application of topical steroids immunohistologically. Materials and Methods: The forearm skin was biopsied before and after 2 weeks' application of clobetasol propionate 0.05% two times a day in one healthy volunteer. The biopsied skin was stained immunohistologically by ant-MLN64, StAR, CPY11A1, cortisol, HSD11B1, HSD11B2, glucocorticoid receptor alpha, glucocorticoid receptor beta (GRB), and mineralocorticoid receptor (MCR) antibodies. The skin biopsy was performed similarly in 19 adult patients with atopic dermatitis who had used TCS for a considerable period. They were 4 TCS present users (TCS+), 12 TCS nonusers with skin manifestation on the biopsied site (TCS-E+) and 3 TCS nonusers without skin manifestation on the biopsied site (TCS-E-). Results: The staining density increased during TCS application in MLN64, cortisol and HSD11B2 in a healthy volunteer. The staining density was stronger in HSD11B2 of the basal layer and MCR of the spinous layer in the TCS-E+ patients than in the TCS+ and TCS-E- patients. The staining density was weaker in MLN64 of the basal and granular layers, HSD11B1 of the basal layer and GRB of the whole layer in the TCS-E+ patients than in the TCS+ and TCS-E- patients. Conclusion: The hypertrophy of the epidermis and insufficient keratinization recognized in the TCS-E+ patients might be caused by the decreased cortisol synthesis regulated by MLN64 and the increased cortisol inactivation by HSD11B2. Decreased GRB and increased MCR might enhance the reactivity of cortisol in the keratinocytes.
引用
收藏
页码:454 / 459
页数:6
相关论文
共 50 条
  • [1] Topical corticosteroids for atopic dermatitis
    Braschi, Emelie
    Young, Jennifer
    Allan, G. Michael
    CANADIAN FAMILY PHYSICIAN, 2024, 70 (09) : 558 - 558
  • [2] Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused
    Haeck, I. M.
    Timmer-de Mik, L.
    Lentjes, E. G. W. M.
    Buskens, E.
    Hijnen, D. J.
    Guikers, C.
    Bruijnzeel-Koomen, C. A. F. M.
    de Bruin-Weller, M. S.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (05) : 979 - 985
  • [3] Low basal serum cortisol in severe atopic dermatitis patients: Potent topical corticosteroids wrongfully accused
    Haeck, I. M.
    Timmer-de Mik, L.
    Lentjes, E.
    Buskens, E.
    Hijnen, D. J.
    Guikers, C.
    Bruijnzeel-Koomen, C. A.
    Bruin-Weller, M. S.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2006, 126 : 99 - 99
  • [4] Fear of topical corticosteroids within Australian atopic dermatitis patients
    Zhao, C. Y.
    Oh, D. D.
    Stalder, J. F.
    Murrell, D. F.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2016, 57 : 18 - 18
  • [5] The use of topical corticosteroids in atopic dermatitis in children
    Cambazard, F
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2005, 132 : 64 - 67
  • [6] Comparative trial of topical corticosteroids in atopic dermatitis
    Uenishi, T
    Sugiura, H
    Tanaka, T
    Uehara, M
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2005, 125 (03) : 607 - 607
  • [7] Lymphoma among patients with atopic dermatitis treated with topical corticosteroids and/or topical calcineurin inhibitors
    Arana, Alejandro
    Wentworth, Charles W.
    Rivero, Elena
    Planas, Estel
    Conde, Eulogio
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : AB3 - AB3
  • [8] Why do patients with atopic dermatitis refuse to apply topical corticosteroids?
    Fukaya, M
    DERMATOLOGY, 2000, 201 (03) : 242 - 245
  • [9] Percutaneous absorption of potent topical corticosteroids in patients with severe atopic dermatitis
    van Velsen, Sara G. A.
    Haeck, Inge M.
    Bruijnzeel-Koomen, Carla A. F. M.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (05) : 911 - 913
  • [10] Topical corticosteroids in atopic dermatitis and the risk of glaucoma and cataracts
    Haeck, Inge M.
    Rouwen, Ton J.
    Timmer-de Mik, Linda
    de Bruin-Weller, Marjolein S.
    Bruijnzeel-Koomen, Carla A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (02) : 275 - 281